osteoporosis semaglutide Type 2 diabetes: may help protect bone health GLP-1 drugs — including Ozempic

Tirzepatide activates both GLP-1 and GIP receptors, leading to reduced hunger, enhanced satiety, and slower gastric emptying

Similar content being viewed by others Introduction In the last decade, there has been considerable change in the number and type of pharmacotherapies available for type 2 diabetes

Stay hydrated: Drink plenty of water to combat dehydration and support digestion

Nutritional Medicine , Second Edition April 2017 Harrison FE, May JM

Resume FARXIGA when the patient is clinically stable and has resumed oral intake Volume Depletion: FARXIGA can cause intravascular volume depletion, which may manifest as symptomatic hypotension or acute transient changes in creatinine